Literature DB >> 21212414

Negative regulation of the Hippo pathway by E3 ubiquitin ligase ITCH is sufficient to promote tumorigenicity.

Zaidoun Salah1, Gerry Melino, Rami I Aqeilan.   

Abstract

The Hippo tumor suppressor pathway, originally defined in fruit flies, regulates cellular proliferation and survival and exerts profound effects on normal mammalian cell fate and tumorigenesis. The present understanding of Hippo pathway components and mechanisms remains incomplete in cancer. WW domain-containing proteins regulate diverse biological processes through interaction with proline-tyrosine (PPxY)-containing targets. In this study, we report that the E3 ubiquitin ligase ITCH regulates stability of LATS1, a serine/threonine kinase in the Hippo pathway, through protein-protein interaction of the PPxY motifs of LATS1 with the WW domains of ITCH. Ubiquitination of LATS1 catalyzed by ITCH stimulated the proteasomal degradation of LATS1. Furthermore, ITCH-mediated degradation of LATS1 was associated with enhanced cell growth, induction of epithelial-mesenchymal transition, and increased tumorigenicity. Conversely, ITCH depletion increased LATS1 levels, enhancing FAS-induced apoptosis and reducing proliferation, survival, and migration. These phenotypes were rescued when both ITCH and LATS1 were depleted. Together, our results reveal a novel functional link between ITCH and the Hippo pathway, deepening their critical roles in tumorigenesis. ©2011 AACR.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21212414     DOI: 10.1158/0008-5472.CAN-10-3516

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  74 in total

1.  Deacetylation of tumor-suppressor MST1 in Hippo pathway induces its degradation through HBXIP-elevated HDAC6 in promotion of breast cancer growth.

Authors:  L Li; R Fang; B Liu; H Shi; Y Wang; W Zhang; X Zhang; L Ye
Journal:  Oncogene       Date:  2015-12-14       Impact factor: 9.867

2.  HECT-type ubiquitin ligase ITCH targets lysosomal-associated protein multispanning transmembrane 5 (LAPTM5) and prevents LAPTM5-mediated cell death.

Authors:  Takaya Ishihara; Jun Inoue; Ken-Ichi Kozaki; Issei Imoto; Johji Inazawa
Journal:  J Biol Chem       Date:  2011-10-18       Impact factor: 5.157

Review 3.  Structural insights into the functional versatility of WW domain-containing oxidoreductase tumor suppressor.

Authors:  Amjad Farooq
Journal:  Exp Biol Med (Maywood)       Date:  2015-02-07

4.  NEDD4 E3 ligase inhibits the activity of the Hippo pathway by targeting LATS1 for degradation.

Authors:  Zaidoun Salah; Sherri Cohen; Ella Itzhaki; Rami I Aqeilan
Journal:  Cell Cycle       Date:  2013-10-07       Impact factor: 4.534

5.  Ubiquitin-specific protease 11 (USP11) functions as a tumor suppressor through deubiquitinating and stabilizing VGLL4 protein.

Authors:  Encheng Zhang; Bing Shen; Xingyu Mu; Yan Qin; Fang Zhang; Yong Liu; Jiantao Xiao; Pingzhao Zhang; Chenji Wang; Mingyue Tan; Yu Fan
Journal:  Am J Cancer Res       Date:  2016-12-01       Impact factor: 6.166

6.  Deubiquitylase USP9X suppresses tumorigenesis by stabilizing large tumor suppressor kinase 2 (LATS2) in the Hippo pathway.

Authors:  Chu Zhu; Xinyan Ji; Haitao Zhang; Qi Zhou; Xiaolei Cao; Mei Tang; Yuan Si; Huan Yan; Li Li; Tingbo Liang; Xin-Hua Feng; Bin Zhao
Journal:  J Biol Chem       Date:  2017-11-28       Impact factor: 5.157

Review 7.  ITCH as a potential therapeutic target in human cancers.

Authors:  Qing Yin; Clayton J Wyatt; Tao Han; Keiran S M Smalley; Lixin Wan
Journal:  Semin Cancer Biol       Date:  2020-03-10       Impact factor: 15.707

Review 8.  YAP and TAZ: a nexus for Hippo signaling and beyond.

Authors:  Carsten Gram Hansen; Toshiro Moroishi; Kun-Liang Guan
Journal:  Trends Cell Biol       Date:  2015-06-02       Impact factor: 20.808

9.  Deubiquitinase YOD1 potentiates YAP/TAZ activities through enhancing ITCH stability.

Authors:  Youngeun Kim; Wantae Kim; Yonghee Song; Jeong-Rae Kim; Kyungjoo Cho; Hyuk Moon; Simon Weonsang Ro; Eunjeong Seo; Yeon-Mi Ryu; Seung-Jae Myung; Eek-Hoon Jho
Journal:  Proc Natl Acad Sci U S A       Date:  2017-04-17       Impact factor: 11.205

10.  The Hippo Pathway Transducers YAP1/TEAD Induce Acquired Resistance to Trastuzumab in HER2-Positive Breast Cancer.

Authors:  Paula González-Alonso; Sandra Zazo; Ester Martín-Aparicio; Melani Luque; Cristina Chamizo; Marta Sanz-Álvarez; Pablo Minguez; Gonzalo Gómez-López; Ion Cristóbal; Cristina Caramés; Jesús García-Foncillas; Pilar Eroles; Ana Lluch; Oriol Arpí; Ana Rovira; Joan Albanell; Sander R Piersma; Connie R Jimenez; Juan Madoz-Gúrpide; Federico Rojo
Journal:  Cancers (Basel)       Date:  2020-04-29       Impact factor: 6.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.